Related Experiment Video
Updated: Jul 21, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Thymoma. Analysis of prognostic factors
M Sonobe1, M Nakagawa, M Ichinose
1Department of Thoracic Surgery, Tenri Hospital, Mishima-cho 200, Tenri, Nara 632-8552, Japan.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi
|March 10, 2001
Summary
Prognostic factors for thymoma, including Masaoka stage and surgical resection extent, were identified. Pure red cell aplasia is a significant risk factor for recurrence and poor survival in thymoma patients.
Area of Science:
- Oncology
- Thoracic Surgery
- Hematology
Background:
- Thymoma is a rare tumor of the thymus gland.
- Prognostic factors for thymoma require further clarification for optimal patient management.
Purpose of the Study:
- To evaluate controversial prognostic factors for thymoma.
- To identify key indicators of recurrence-free and overall survival in thymoma patients.
Main Methods:
- Retrospective analysis of 72 thymoma patients treated between 1966 and 1997.
- Kaplan-Meier survival analysis and log-rank tests for prognostic factors.
- Multivariate Cox proportional hazards modeling for risk factor identification.
Main Results:
- Masaoka stage, extent of surgical resection, and association with pure red cell aplasia significantly influenced recurrence-free and overall survival.
- Stage IV tumors and pure red cell aplasia were identified as independent risk factors for recurrence.
- Pure red cell aplasia was associated with a poorer overall survival prognosis.
Conclusions:
- Masaoka stage, surgical resection extent, and pure red cell aplasia are critical prognostic factors for thymoma.
- Multidisciplinary treatment strategies for advanced (Stage IV) thymomas and improved management of pure red cell aplasia warrant further investigation.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...